Breaking News

BioLife Solutions Acquires Astero Bio

Gains products that automate the thawing process for high-value biologic therapies

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioLife Solutions has entered into an agreement to acquire Astero Bio, a privately-held innovator in the design, development and commercialization of novel automated thawing devices, for $8 million.   This transaction is expected to further strengthen BioLife’s position as a supplier of disruptive, enabling solutions used in the manufacture, storage and distribution of cell and gene therapies. Astero’s ThawSTAR product line broadens BioLife’s bioproduction tools portfolio and i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters